Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity

Endocrinology

Volumn 150, Issue 8, 2009, Pages 3709-3716

  McEuen, Jonathan G ^a   Semsar, Katharine A ^a,b   Lim, Maria A ^a   Bale, Tracy L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; ESTRUS CYCLE; FEMALE; GENOTYPE; LATENT PERIOD; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX DIFFERENCE;

ANIMALS; AUTORADIOGRAPHY; CITALOPRAM; CORTICOTROPIN-RELEASING HORMONE; FEMALE; GENOTYPE; HINDLIMB SUSPENSION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS;

EID: 67651173044     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1721     Document Type: Article

References (65)

1. Bale TL 2006 Stress sensitivity and the development of affective disorders. Horm Behav 50:529-533
2. Gorman JM 2006 Gender differences in depression and response to psychotropic medication. Gend Med 3:93-109
3. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS 1994 Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19
4. Heninger GR 1997 Serotonin, sex, and psychiatric illness. Proc Natl Acad Sci USA 94:4823-4824
5. Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG 1994 Sex and depression in the National Comorbidity Survey. II. Cohort effects. J Affect Disord 30:15-26
6. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lépine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK 1996 Cross-national epidemiology of major depression and bipolar disorder. JAMA 276:293-299
7. Becker JB, Monteggia LM, Perrot-Sinal TS, Romeo RD, Taylor JR, Yehuda R, Bale TL 2007 Stress and disease: is being female a predisposing factor? J Neurosci 27:11851-11855
8. Lopez JF, Vasquez DM, Chalmers DT, Watson SJ 1997 Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide. Ann NY Acad Sci 29:106-134
9. Nemeroff CB, Vale WW 2005 The neurobiology of depression: inroads to treatment and new drug discovery. J Clin Psychiatry 66(Suppl 7):5-13
10. Strock M 2002 Depression. Bethesda, MD: National Institute of Mental Health; 1-25
11. Vergne DE, Nemeroff CB 2006 The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression. Curr Psychiatry Rep 8:452-457
12. Mann JJ, McBride PA, Brown RP, Linnoila M, Leon AC, DeMeo M, Mieczkowski T, Myers JE, Stanley M 1992 Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 49:442-446
13. Mann JJ, McBride PA, Anderson GM, Mieczkowski TA 1992 Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biol Psychiatry 32:243-257
14. Carrasco GA, Van de Kar LD 2003 Neuroendocrine pharmacology of stress. Eur J Pharmacol 463:235-272
15. Lee HS, Kim MA, Valentino RJ, Waterhouse BD 2003 Glutamatergic afferent projections to the dorsal raphe nucleus of the rat. Brain Res 963:57-71
16. Shekhar A, Truitt W, Rainnie D, Sajdyk T 2005 Role of stress, corticotropin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 8:209-219
17. Berretta S 2005 Cortico-amygdala circuits: role in the conditioned stress response. Stress 8:221-232
18. Chamas FM, Underwood MD, Arango V, Serova L, Kassir SA, Mann JJ, Sabban EL 2004 Immobilization stress elevates tryptophan hydroxylase mRNA and protein in the rat raphe nuclei. Biol Psychiatry 55:278-283
19. Daugherty WP, Corley KC, Phan TH, Boadle-Biber MC 2001 Further studies on the activation of rat median raphe serotonergic neurons by inescapable sound stress. Brain Res 923:103-111
20. Keeney A, Jessop DS, Harbuz MS, Marsden CA, Hogg S, Blackburn-Munro RE 2006 Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice. J Neuroendocrinol 18:330-338
21. Kirby LG, Pernar L, Valentino RJ, Beck SG 2003 Distinguishing characteristics of serotonin and non-serotonin-containing cells in the dorsal raphe nucleus: electrophysiological and immunohistochemical studies. Neuroscience 116:669-683
22. Kirby LG, Rice KC, Valentino RJ 2000 Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22:148-162
23. Roche M, Commons KG, Peoples A, Valentino RJ 2003 Circutry underlying regulation of the serotonergic system by swim stress. J Neurosci 23:970-977
24. Tan H, Zhong P, Yan Z 2004 Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. J Neurosci 24:5000-5008
25. Valentino RJ, Liouterman L, Van Bockstaele EJ 2001 Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus. J Comp Neurol 435:450-463
26. Joffe H, Cohen LS 1998 Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol Psychiatry 44:798-811
27. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP 1996 Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16:325-344
28. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF 2000 Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410-414
29. Bale TL, Vale WW 2003 Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J Neurosci 23:5295-5301
30. McEuen JG, Beck SG, Bale TL 2008 Failure to mount adaptive responses to stress results in dysregulation and cell death in the midbrain raphe. J Neurosci 28:8169-8177
31. Weber M, Talmon S, Schulze I, Boeddinghaus C, Gross G, Schoemaker H, Wicke KM 2008 Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake. Psychopharmacology (Berl) 203:753-762
32. Fish EW, Faccidomo S, Gupta S, Miczek KA 2004 Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups. J Pharmacol Exp Ther 308:474-480
33. 1 receptor and serotonergic system. Eur J Pharmacol 589:117-121
34. Chenu F, Guiard BP, Bourin M, Gardier AM 2006 Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behav Brain Res 172:256-263
35. Dulawa SC, Holick KA, Gundersen B, Hen R 2004 Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29:1321-1330
36. Teegarden SL, Bale TL 2007 Decreases in dietary preference produce increased emotionality and risk for dietary relapse. Biol Psychiatry 61:1021-1029
37. Paxinos G, Franklin KBJ 2003 The mouse brain in stereotactic coordinates. Compact 2nd ed. New York: Elsevier/Academic Press
38. Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Lee KF 2002 Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci 22:193-199
39. Linthorst AC, Peñalva RG, Flachskamm C, Holsboer F, Reul JM 2002 Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism. Eur J Neurosci 16:2441-2452
40. Dranovsky A, Hen R 2006 Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 59:1136-1143
41. Mueller BR, Bale TL 2007 Early prenatal stress impact on coping strategies and learning performance is sex dependent. Physiol Behav 91:55-65
42. McEwen BS 2003 Mood disorders and allostatic load. Biol Psychiatry 54:200-207
43. Mallo T, Koiv K, Koppel I, Raudkivi K, Uustare A, Rinken A, Timmusk T, Harro J 2008 Regulation of extracellular serotonin levels and brain-derived neurotrophic factor in rats with high and low exploratory activity. Brain Res 1194:110-117
44. Adamec R, Head D, Blundell J, Burton P, Berton O 2006 Lasting anxiogenic effects of feline predator stress in mice: sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience. Physiol Behav 88:12-29
45. Mineur YS, Belzung C, Crusio WE 2006 Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behav Brain Res 175:43-50
46. Kelliher P, Kelly JP, Leonard BE, Sánchez C 2003 Effects of acute and chronic administration of selective monoamine re-uptake inhibitors in the rat forced swim test. Psychoneuroendocrinology 28:332-347
47. Griebel G, Moreau JL, Jenck F, Misslin R, Martin JR 1994 Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology (Berl) 113:463-470
48. Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE 2004 The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55:1171-1178
49. Dazzi L, Seu E, Cherchi G, Biggio G 2005 Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress. Eur Neuropsychopharmacol 15:283-290
50. Gerdelat-Mas A, Loubinoux I, Tombari D, Rascol O, Chollet F, Simonetta-Moreau M 2005 Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage 27:314-322
51. Hesketh S, Jessop DS, Hogg S, Harbuz MS 2005 Differential actions of acute and chronic citalopram on the rodent hypothalamic-pituitary-adrenal axis response to acute restraint stress. J Endocrinol 185:373-382
52. den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS 1987 Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol 2:21-32
53. Grillon C, Levenson J, Pine DS 2007 A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 32:115-331
54. Micevych PE, Mermelstein PG 2008 Membrane estrogen receptors acting through metabotropic glutamate receptors: an emerging mechanism of estrogen action in brain. Mol Neurobiol 38:66-77
55. Durand M, Berton O, Aguerre S, Edno L, Combourieu I, Mormède P, Chaouloff F 1999 Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis in SHR and WKY rats. Neuropharmacology 38:893-907
56. 11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J Neurosci 26:4638-4643
57. 1A receptor binding in limbic regions in patients with anxiety disorders. Mol Psychiatry 10.1038/mp.2008.35
58. Romeo RD, McCarthy JB, Wang A, Milner TA, McEwen BS 2005 Sex differences in hippocampal estradiol-induced N-methyl-D-aspartic acid binding and ultrastructural localization of estrogen receptor-α. Neuroendocrinology 81:391-399
59. Hariri AR, Holmes A 2006 Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Neurosci 10:182-191
60. Jennings KA, Loder MK, Sheward WJ, Pei Q, Deacon RM, Benson MA, Olverman HJ, Hastie ND, Harmar AJ, Shen S, Sharp T 2006 Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci 26:8955-8964
61. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA 2003 Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54:960-971
62. Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ 2006 Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 163:52-58
63. Handa RJ, Burgess LH, Kerr JE, O'Keefe JA 1994 Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis.Horm Behav 28:464-476
64. Finley PR 1994 Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. Ann Pharmacother 28:1359-1369
65. Paxinos G, Watson KB 2001 The mouse brain in stereotaxic coordinates. 2nd ed. New York: Elsevier